LEGN (Legend Biotech) Float Percentage Of Total Shares Outstanding: 41.98% (As of Jun. 30, 2026)


LEGN Legend Biotech Corp LEGN
73 GF Score
Price $28.88
GF Value $98.55
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Legend Biotech Float Percentage Of Total Shares Outstanding?

Legend Biotech LEGN -1.67% 73 Float Percentage Of Total Shares Outstanding is 41.98% as of Jun. 30, 2026. GuruFocus rates LEGN with a GF Score™ of 73/100 and a GF Value™ of $98.55 (Possible Value Trap). The stock has 3 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Legend Biotech's float shares is 81.20 Mil. Legend Biotech's total shares outstanding is 193.44 Mil. Legend Biotech's float percentage of total shares outstanding is 41.98%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Legend Biotech's Insider Ownership is 0.02%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Legend Biotech's Institutional Ownership is 51.80%.

LEGN
73GF Score
Legend Biotech Corp LEGN
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Legend Biotech Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Legend Biotech's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=81.20/193.44
=41.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 41.98% mean?
Legend Biotech (LEGN) has a Float Percentage Of Total Shares Outstanding of 41.98% as of Jun. 30, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Legend Biotech and its competitors.
Is Legend Biotech's Float Percentage Of Total Shares Outstanding too high?
Legend Biotech's current Float Percentage Of Total Shares Outstanding is 41.98%. Overall, Legend Biotech has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Legend Biotech's Float Percentage Of Total Shares Outstanding compare to TVTX and ORKA?
Legend Biotech's Float Percentage Of Total Shares Outstanding of 41.98% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Legend Biotech and its competitors. Legend Biotech's current Float Percentage Of Total Shares Outstanding is 41.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Legend Biotech stock overvalued right now?
Based on GuruFocus' analysis, Legend Biotech (LEGN) is currently considered Possible Value Trap. The stock's GF Value™ is $98.55, compared to a current price of $28.88 — trading 70.7% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 41.98%. Legend Biotech's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Legend Biotech (LEGN), the current Float Percentage Of Total Shares Outstanding is 41.98% as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Legend Biotech (LEGN) Overvalued in 2026?

Based on GuruFocus' analysis, Legend Biotech stock appears to be undervalued. The current stock price of $28.88 is trading 70.7% below its estimated GF Value™ of $98.55. GuruFocus considers Legend Biotech to be Possible Value Trap.

Key valuation signals for LEGN:

  • Float Percentage Of Total Shares Outstanding: 41.98%
  • GF Value™: $98.55 vs. price of $28.88 (70.7% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the LEGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Legend Biotech Business Description

Other Exchanges 9LB:Germany
Address 2101 Cottontail Lane, Somerset, NJ, USA, 08873
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
73GF Score

Get the complete analysis for LEGN

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.88
Price
$98.55
GF Value